BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15953282)

  • 1. A case of postprandial cluster-like headache with prolactinoma: dramatic response to cabergoline.
    Negoro K; Kawai M; Tada Y; Ogasawara J; Misumi S; Morimatsu M
    Headache; 2005 May; 45(5):604-6. PubMed ID: 15953282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Symptomatic episodic cluster headache as the first symptom of a prolactinoma].
    Soto-Cabrera E; Chávez-Valencia V; Zermeño-Pohls F; González-Aguilar A
    Rev Neurol; 2009 Aug 1-15; 49(3):165-6. PubMed ID: 19621313
    [No Abstract]   [Full Text] [Related]  

  • 3. SUNCT syndrome in a patient with prolactinoma and cabergoline-induced attacks.
    Jiménez Caballero PE
    Cephalalgia; 2007 Jan; 27(1):76-8. PubMed ID: 17212687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of third nerve palsy following treatment of prolactinoma with cabergoline.
    Harries AM; Gittoes NJ; Mitchell RD
    Acta Neurochir (Wien); 2010 Oct; 152(10):1741-3. PubMed ID: 20623359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic degeneration of macroprolactinoma on long-term cabergoline.
    Sharif DA; Nkonge FM; Chawda S; Benjamin J; Stojanović ND
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3593-4. PubMed ID: 20685886
    [No Abstract]   [Full Text] [Related]  

  • 6. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 17-year-old female with secondary amenorrhea, galactorrhea, and headaches.
    Frohlich DM; Caldwell KJ; Rohrs H; Kelly MN
    J Pediatr Health Care; 2015; 29(2):205-11. PubMed ID: 25547318
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment.
    Feneberg E; Gahr M; Baumgarten E; Connemann B; Merger S; Özpeynirci Y; Schönfeldt-Lecuona C
    J ECT; 2015 Jun; 31(2):e28-9. PubMed ID: 26000778
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.
    Dash S; Annamalai AK; Simpson HL; Sarkies N; Antoun NM; Mannion R
    QJM; 2013 Jan; 106(1):85. PubMed ID: 22075008
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma.
    Davie M
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):473-4. PubMed ID: 18070857
    [No Abstract]   [Full Text] [Related]  

  • 11. Impressive shrinkage of a giant prolactinoma treated with cabergoline in a prepubescent girl. What now?
    Christoforidis A; Tsakalides C; Anastasiou A; Pavlaki A; Dimitriadou M
    Neuro Endocrinol Lett; 2013; 34(4):275-7. PubMed ID: 23803868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant pubertal prolactinoma: Complete resolution following short term carbegoline treatment.
    Oguz A; Tuzun D; Sahin M; Gul K
    Niger J Clin Pract; 2016; 19(5):685-7. PubMed ID: 27538562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive reduction of tumour load and normalisation of hyperprolactinaemia after high dose cabergoline in metastasised prolactinoma causing thoracic syringomyelia.
    van Uum SH; van Alfen N; Wesseling P; van Lindert E; Pieters GF; Nooijen P; Hermus AR
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1489-91. PubMed ID: 15377706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant prolactinoma presented as unilateral exophthalmos in a prepubertal boy: response to cabergoline.
    Krassas GE; Pontikides N; Kaltsas T
    Horm Res; 1999; 52(1):45-8. PubMed ID: 10640900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
    Kawabata Y; Ueno Y; Horikawa F; Miyake H; Miki N; Ono M
    Surg Neurol; 2008 Jan; 69(1):85-8; discussion 88. PubMed ID: 17967478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid improvement in visual loss with cabergoline treatment in a giant prolactinoma case: 5 years survey.
    Tasan E; Hanimoglu H; Turgut S; Ilhan MM; Evran S; Kaynar MY
    Neuro Endocrinol Lett; 2015; 36(1):28-30. PubMed ID: 25789596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline treatment in a case of macroprolactinoma after delivery.
    Falsetti L
    Acta Eur Fertil; 1995; 26(3):105-7. PubMed ID: 9098469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterlike headache as first manifestation of a prolactinoma.
    Porta-Etessam J; Ramos-Carrasco A; Berbel-García A ; Martínez-Salio A; Benito-León J
    Headache; 2001; 41(7):723-5. PubMed ID: 11554962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic shrinkage of a giant prolactinoma in a male patient under medical management.
    Ippersiel W; Misson N; Donckier JE
    Acta Clin Belg; 2012; 67(2):140-1. PubMed ID: 22712173
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?
    Besouw MT; Levtchenko EN; Willemsen MA; Noordam K
    Pediatr Nephrol; 2008 Feb; 23(2):307-10. PubMed ID: 17638022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.